Altınok, D. Et Al. 2018. CCND1- G870A and TP53 Pro72Arg Polymorphisms in Breast Cancer. FEBS 2018, ADVANCED COURSE,Emerging issues of breast cancer research: tumour heterogeneity, immunotherapy and cellular metabolısm .

Altınok, D., ÜREN, N., ERGÜL, E., KORAK, T., SAZCI, A., & GÜLLÜOĞLU, M. B., (2018). CCND1- G870A and TP53 Pro72Arg Polymorphisms in Breast Cancer . FEBS 2018, ADVANCED COURSE,Emerging issues of breast cancer research: tumour heterogeneity, immunotherapy and cellular metabolısm

Altınok, Duygu Et Al. "CCND1- G870A and TP53 Pro72Arg Polymorphisms in Breast Cancer," FEBS 2018, ADVANCED COURSE,Emerging issues of breast cancer research: tumour heterogeneity, immunotherapy and cellular metabolısm, 2018

Altınok, Duygu Et Al. "CCND1- G870A and TP53 Pro72Arg Polymorphisms in Breast Cancer." FEBS 2018, ADVANCED COURSE,Emerging issues of breast cancer research: tumour heterogeneity, immunotherapy and cellular metabolısm , 2018

Altınok, D. Et Al. (2018) . "CCND1- G870A and TP53 Pro72Arg Polymorphisms in Breast Cancer." FEBS 2018, ADVANCED COURSE,Emerging issues of breast cancer research: tumour heterogeneity, immunotherapy and cellular metabolısm .

@conferencepaper{conferencepaper, author={Duygu Altınok Et Al. }, title={CCND1- G870A and TP53 Pro72Arg Polymorphisms in Breast Cancer}, congress name={FEBS 2018, ADVANCED COURSE,Emerging issues of breast cancer research: tumour heterogeneity, immunotherapy and cellular metabolısm}, city={}, country={}, year={2018}}